Red Spruce Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,325
| Closed | -$523K | – | 93 |
|
|
2023
Q1 | $523K | Sell |
6,325
-255
| -4% | -$21.1K | 0.31% | 78 |
|
|
2022
Q4 | $491K | Hold |
6,580
| – | – | 0.31% | 77 |
|
|
2022
Q3 | $544K | Hold |
6,580
| – | – | 0.38% | 70 |
|
|
2022
Q2 | $626K | Buy |
6,580
+549
| +9% | +$52.2K | 0.42% | 69 |
|
|
2022
Q1 | $710K | Buy |
6,031
+735
| +14% | +$86.5K | 0.4% | 71 |
|
|
2021
Q4 | $686K | Buy |
5,296
+885
| +20% | +$115K | 0.38% | 78 |
|
|
2021
Q3 | $499K | Buy |
4,411
+34
| +0.8% | +$3.85K | 0.29% | 84 |
|
|
2021
Q2 | $453K | Buy |
4,377
+859
| +24% | +$88.9K | 0.27% | 83 |
|
|
2021
Q1 | $294K | Buy |
+3,518
| New | +$294K | 0.19% | 89 |
|